XINHUA JERUSALEM - Tel Aviv University scientists said on Monday that they had printed the first 3D heart, by using a patient's cells and scans. The heart, which was produced in a lab, completely ...

3D printing technology is already changing the way we produce things. Opening up a world of limitless possibilities, we now have the largest 3D-printed building in Florida and even a 3D-printed ...

Advancing structural and functional maturation of stem cell–derived cardiomyocytes remains a key challenge for applications in disease modeling, drug screening, and heart repair. Here, we sought to ...

The 3D printed heart can’t function in a body yet, however. While it can pull in blood, it can’t yet pump it out. Researchers still need to teach the heart how to beat, then test it in animal models — ...

Existing methods typically use multi-view diffusion models for 3D generation, but they often face inconsistent view issues, which hinder high-quality 3D human generation. To address this, we propose ...

3D models are unique in disease simulation. For example, it is particularly suitable for studying the interaction of different cells in the heart during the pathological process. Moreover, live ...

If you drill both straw sized (like we did), you can use some modeling clay ... put your heart model to work! In this simple model the first bottle is the atrium of the heart, the second bottle is the ...

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are cultured heart muscle cell models widely used to study a variety of human heart disease and responses to experimental drugs.

You wait to order, trying to decide between buying a new $40 reusable mug at the counter or walking out with a little paper cup in your hand and a pang of guilt in your heart. There’s some good ...

Against the backdrop of the great digital expanse, CLAY orchestrates a vibrant explosion of 3D creativity, marking the dawn of imagination unleashed. Evolution of human innovation, from primitive ...

In this Q&A, Keith Murphy, CEO of Organovo, discusses how the shift from animal models to 3D human tissues can transform the preclinical space. Among his many insights, he details the limitations of ...